Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Midazolam vs Dexmedetomidine for Premedication in Pediatric Hernia Surgery
IRCT20240713062419N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in inguinal hernia comparing Intranasal midazolam with Intranasal dexmedetomidine (2 arms). Primary endpoints: Reduction in preoperative anxiety and Sedation level. Started Sep 2024; status: completed.
02
Drugs
midazolamdexmedetomidine
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on IRCT20240713062419N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240713062419N1.